dalteparin has been researched along with Diabetic Glomerulosclerosis in 4 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, C | 1 |
| Wu, T | 1 |
| Huang, C | 1 |
| Benck, U | 1 |
| Haeckel, S | 1 |
| Clorius, JH | 1 |
| van der Woude, FJ | 1 |
| Hiwatashi, A | 1 |
| Usui, JI | 1 |
| Sato, C | 1 |
| Hasegawa, Y | 1 |
| Yamagata, K | 1 |
| Nielsen, S | 1 |
| Schmitz, A | 1 |
| Bacher, T | 1 |
| Rehling, M | 1 |
| Ingerslev, J | 1 |
| Mogensen, CE | 1 |
2 trials available for dalteparin and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Proteinuria-lowering effect of heparin therapy in diabetic nephropathy without affecting the renin-angiotensin-aldosterone system.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Diabetic Nephropathies; Enoxaparin; Female; Fibrinolytic A | 2007 |
Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin.
Topics: Adult; Aged; Albuminuria; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Capi | 1999 |
2 other studies available for dalteparin and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Low molecular weight heparin reduces triglyceride, VLDL and cholesterol/HDL levels in hyperlipidemic diabetic patients on hemodialysis.
Topics: Adult; Aged; Anticoagulants; Cholesterol; Cholesterol, HDL; Cholesterol, VLDL; Cross-Over Studies; D | 1998 |
Induction of hemodialysis therapy in a case with factor XIII deficiency.
Topics: Catheters, Indwelling; Dalteparin; Diabetic Nephropathies; Factor XIII Deficiency; Female; Fibrinoly | 2011 |